The psychedelic renaissance is here. After decades of significant research being closed down, we are now in the midst of an exciting re-emergence of scholarship and research to explore the healing potential of these amazing compounds. Specifically, studies of MDMA Assisted Therapy have shown to significantly reduce symptoms of severe PTSD in 88% of participants with 67% of participants no longer meeting the diagnostic criteria for this indication.* The FDA has designated MDMA assisted therapy as a breakthrough therapy. This treatment is very promising for survivors of sexual assault who suffer from PTSD.
This introductory workshop to psychedelic assisted therapy will provide an overview of the history and types of these medicines, the mechanisms of action, the course of therapy and the role of the therapist. The workshop will address common misconceptions of these medicines and demonstrate their potential to transform mental health treatment.
*MAPS PBC Completes Second Phase 3 “MAPP2” Trial of MDMA-Assisted Therapy for Treatment of PTSD
Nov 17, 2022 | News, Press Releases
Norma Stevens serves as the Lead Therapist for Operations at Sunstone Therapies in the Bill Richards Center for Healing in Rockville, MD. She has worked as a therapist for fifteen years and has a deep passion for psychedelic assisted therapy. Norma brings a wealth of knowledge and a compassionate approach to her role, fostering healing and transformation for individuals seeking support at Sunstone Therapies.
In 2020, she served as a research therapist in a study using psilocybin-assisted therapy to treat depression in cancer patients. Currently, Norma serves as a research therapist for the Multidisciplinary Association for Psychedelic Studies, (MAPS), Expanded Access program, providing MDMA-assisted therapy for chronic PTSD and a Dyad study providing MDMA assisted therapy for cancer patients and a concerned significant other. She has recently been approved for a Consultant Training program for MAPS and serves as a Mentor Lead Therapist for psilocybin assisted therapy studies for CompassPathways.
